From the Journals

Exercise timing may dictate obesity, type 2 diabetes risk


 

No association between evening activity and type 2 diabetes risk

In the second study, the team studied 93,095 persons in the UK Biobank, with a mean age of 62 years and no history of type 2 diabetes, who wore a wrist accelerometer for 1 week.

The movement data were used to estimate the metabolic equivalent of task, which was then summed into the total physical activity completed in the morning, afternoon, and evening and linked to the development of incident type 2 diabetes.

After adjustment for potential confounding factors, both morning and afternoon physical activity were associated with a reduced risk of developing type 2 diabetes, at hazard ratios of 0.90 (P = 7 × 10-8) and 0.91 (P = 1 × 10-5), respectively.

However, there was no association between evening activity and the risk for type 2 diabetes, at a hazard ratio of 0.95 (P = .07).

The team found, however, that MVPA and vigorous physical activity were associated with a reduced risk for type 2 diabetes at all times of day.

Dr. Patel’s study was supported in part by National Institutes of Health grants. No other funding was declared. No relevant financial relationships were declared.

A version of this article appeared on Medscape.com.

Pages

Recommended Reading

Experts debate low-carb diets for people with diabetes
MDedge Endocrinology
Low-dose aspirin cuts type 2 diabetes risk in over-65s
MDedge Endocrinology
Night owls have higher risk of developing type 2 diabetes
MDedge Endocrinology
Diabetes patients satisfied with continuous glucose monitors
MDedge Endocrinology
Heart attack deaths static in those with type 1 diabetes
MDedge Endocrinology
SGLT2 inhibitors: No benefit or harm in hospitalized COVID-19
MDedge Endocrinology
COVID booster may transiently raise glucose levels in T1D
MDedge Endocrinology
Smartphones for children with type 1 diabetes: Cause for concern?
MDedge Endocrinology
Islet, kidney transplants boost survival in type 1 diabetes
MDedge Endocrinology
Beyond A1c: Implementing the new ESC 2023 guidelines
MDedge Endocrinology